Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Alpha Cognition Inc.
Opaleye Management Inc. has filed a Form 4 statement regarding changes in its beneficial ownership of Alpha Cognition Inc. securities. The report details equity transactions that occurred on October 15, 2026.…more
Alpha Cognition Inc.
Opaleye Management Inc. has filed a Form 4 report regarding their beneficial ownership of Alpha Cognition Inc. securities. This filing reflects a change in the holdings of a major shareholder or insider.…more
Alpha Cognition Inc.
Opaleye Management Inc. reported a change in its beneficial ownership of Alpha Cognition Inc. securities as of September 24, 2026. This filing is a Form 4 statement detailing the transaction and updated holdings of the reporting entity.…more
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Alpha Cognition Files Patent Application for ZUNVEYL Manufacturing Process…more
Alpha Cognition announced that the USPTO has published its patent application covering the manufacturing process for its Alzheimer's drug, ZUNVEYL. While this strengthens intellectual property, it does not represent a direct financial impact or regulatory approval.…more
●●●●●●●● ●●●●● ●●●●●●
Alpha Cognition announced initial results from its CONVERGE program, analyzing 180-day medication patterns for patients receiving ZUNVEYL and other AChEI therapies. The study provides insights into real-world therapeutic dosing and medication regimens in long-term care settings.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.